Bulk Suggestion Bulk ID: cthulhudagod/11.21.24-08:40PM
Created at: Nov, 21, 2024 8:40 p.m.
Author: cthulhudagod
Related Deck: 1675118865074
New Note
Rationale for new note

DVT - added cards for proximal

Text
What is the recommended management and duration for a unprovoked proximal DVT

{{c1::DOAC (e.g. apixaban) for 3-6 months, followed by consideration of extended therapy}}
Text
What is the recommended management and duration for a <u>unprovoked</u>&nbsp;<b>proximal DVT</b>?&nbsp;<br><br>{{c1::DOAC (e.g. apixaban) for 3-6 months, followed by consideration of extended therapy}}
Extra


Do not use apixaban if CrCL <25mL/min
Extra
<img src="b365bc4eb448b2c68c6fa948fc57641b.webp"><br><br>Do not use apixaban if CrCL &lt;25mL/min
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
Oxford Handbook
Empty field
Oxford Handbook
First Aid
Empty field
First Aid
AMBOSS
Empty field
AMBOSS
eTG Complete
Empty field
eTG Complete
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Source
eTG Complete Venous thromboembolism (VTE) treatment&nbsp;<a href="https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&amp;guidelinePage=Cardiovascular&amp;topicfile=cardiovascular-disease-risk-stratification&amp;guidelinename=auto%C2%A7ionId=c_CVG_Venous-thromboembolism-treatmenttopic_14#c_CVG_Venous-thromboembolism-treatmenttopic_14">https://tgldcdp-tg-org-au.eu1.proxy.openathens.net/viewTopic?etgAccess=true&amp;guidelinePage=Cardiovascular&amp;topicfile=cardiovascular-disease-risk-stratification&amp;guidelinename=auto&amp;sectionId=c_CVG_Venous-thromboembolism-treatmenttopic_14#c_CVG_Venous-thromboembolism-treatmenttopic_14</a>&nbsp;Accessed 22 November 2024.<br><br><a href="https://emedici.com/app/share/question/1150">https://emedici.com/app/share/question/1150</a>
One by one
Empty field
One by one
Tags
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Subjects::Cardiology::13_Vascular_Pathology::Peripheral_Vascular_Pathology::Deep_Vein_Thrombosis::10_Management #Malleus_CM::#Yield::High